Clinical Trials Browser

Phase 2/3 × Completed × Small Cell Lung Carcinoma × Clear all

NCT03098030 2020-12-09

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase 2/3 Completed

483 enrolled 19 charts

Small Cell Lung Carcinoma

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Phase 2/3 Completed

Small Cell Lung Carcinoma

NCT00930891 2016-03-10

CPC

Phase 2/3 Completed

Small Cell Lung Carcinoma

NCT00290953 2008-12-23

SESAME

Phase 2/3 Completed

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma